| Drug Name: | Guanabenz (5051-62-7) |
|---|---|
| PubChem ID: | 5702063 |
| SMILES: | C1=CC(=C(C(=C1)Cl)/C=N/N=C(N)N)Cl |
| InchiKey: | WDZVGELJXXEGPV-YIXHJXPBSA-N |
| Therapeutic Category: | Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-2 Receptor Agonists, Adrenergic alpha-Agonists, Antihypertensive Agents, Cardiovascular Agents, Neurotransmitter Agents |
| Molecular Weight (dalton) | : | 231.086 |
| LogP | : | 1.6007 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 76.76 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category